|
WO2021070125A1
|
|
Novel amide derivatives of linagliptin and process for the preparation thereof
|
|
WO2021070066A1
|
|
Improved topical composition of colchicine
|
|
WO2020089826A1
|
|
Ready to use intravenous infusion of brivaracetam or salt thereof
|
|
WO2020021372A1
|
|
Nasal drug delivery system of brivaracetam or salt thereof thereof
|
|
WO2020003107A1
|
|
Low dose oral pharmaceutical composition of pirfenidone or salt thereof
|
|
EP3802502A1
|
|
Antifungal cuticle oil composition
|
|
WO2019162746A1
|
|
Novel derivatives of paliperidone and process for the preparation thereof
|
|
WO2019087054A1
|
|
Novel pharmaceutical composition comprising dpp-4 inhibitor, alpha-lipoic acid and vitamin b12
|
|
WO2019064165A1
|
|
Synergistic pharmaceutical composition of acyclovir or penciclovir, docosanol and hydrocortisone
|
|
WO2019073321A1
|
|
Effervescent compositions comprising rifaximin
|
|
WO2019064090A1
|
|
Novel pharmaceutical composition comprising mefenamic acid and other analgesic
|
|
WO2019003098A1
|
|
Topical pharmaceutical composition comprising miconazole and luliconazole or salts thereof
|
|
WO2019003062A1
|
|
Tamper-proof dosage form comprising pharmaceutically active agent
|
|
WO2018193367A1
|
|
Novel pharmaceutical composition comprising combination of alcaftadine and nepafenac along with antibacterial and/or antiviral an/or antifungal drug
|
|
WO2018193346A1
|
|
Effervescent compositions comprising chlorpromazine or salt thereof
|
|
WO2018185669A1
|
|
Effervescent compositions comprising saxagliptin or salt thereof
|
